Metraipolis › archive › dc_be928cf18bcc
Screening, Risk Reduction Strategies, and Clinical Management of Unaffected Carriers of BRCA1 or BRCA2 Pathogenic Variants — Europe PMC PMID:41488281
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41488281
- DOI
- 10.14740/wjon2692
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T13:53:13.360Z
- SHA-256 of the archived text
351a3954b435b37a86ada6d7f0f50286d80987c5840a419682cc551bc44d2a12- Stable URL of this page
https://metraipolis.com/documento/dc_be928cf18bcc
How to cite
Screening, Risk Reduction Strategies, and Clinical Management of Unaffected Carriers of BRCA1 or BRCA2 Pathogenic Variants — Europe PMC PMID:41488281 — Europe PMC (en), https://europepmc.org/article/MED/41488281 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_be928cf18bcc (Metraipolis archive dc_be928cf18bcc, sha256 351a3954b435b37a86ada6d7f0f50286d80987c5840a419682cc551bc44d2a12)
BibTeX
@misc{dcbe928cf18bcc,
title = {Screening, Risk Reduction Strategies, and Clinical Management of Unaffected Carriers of BRCA1 or BRCA2 Pathogenic Variants — Europe PMC PMID:41488281},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41488281},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_be928cf18bcc; sha256 351a3954b435b37a86ada6d7f0f50286d80987c5840a419682cc551bc44d2a12},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41488281. Agents can read the archived copy with the MCP tool read_document.